213 related articles for article (PubMed ID: 19323781)
21. Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome.
Lampinen M; Oberg G; Venge P; Carlson M
APMIS; 2006 Nov; 114(11):757-63. PubMed ID: 17078855
[TBL] [Abstract][Full Text] [Related]
22. The role of Th17/IL-17 on eosinophilic inflammation.
Dias PM; Banerjee G
J Autoimmun; 2013 Feb; 40():9-20. PubMed ID: 22906357
[TBL] [Abstract][Full Text] [Related]
23. Resolution of hypophosphatemia is associated with recovery of hepatic function in children with fulminant hepatic failure.
Quirós-Tejeira RE; Molina RA; Katzir L; Lie A; Vargas JH; Ament ME; McDiarmid SV; Martín MG
Transpl Int; 2005 Sep; 18(9):1061-6. PubMed ID: 16101727
[TBL] [Abstract][Full Text] [Related]
24. Decreased protein C activation in patients with fulminant hepatic failure.
Yamaguchi M; Gabazza EC; Taguchi O; Yano Y; Ikoma J; Kaito M; Kojima Y; Imoto I; Satomi A; D'Alessandro-Gabazza CN; Hayashi T; Moriwaki H; Suzuki K; Adachi Y
Scand J Gastroenterol; 2006 Mar; 41(3):331-7. PubMed ID: 16497622
[TBL] [Abstract][Full Text] [Related]
25. High mobility group box 1 protein as a marker of hepatocellular injury in human liver transplantation.
Ilmakunnas M; Tukiainen EM; Rouhiainen A; Rauvala H; Arola J; Nordin A; Mäkisalo H; Höckerstedt K; Isoniemi H
Liver Transpl; 2008 Oct; 14(10):1517-25. PubMed ID: 18825712
[TBL] [Abstract][Full Text] [Related]
26. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure.
Macquillan GC; Seyam MS; Nightingale P; Neuberger JM; Murphy N
Liver Transpl; 2005 Sep; 11(9):1073-9. PubMed ID: 16123967
[TBL] [Abstract][Full Text] [Related]
27. TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas.
Thielen C; Radermacher V; Trimeche M; Roufosse F; Goldman M; Boniver J; de Leval L
Leuk Res; 2008 Sep; 32(9):1431-8. PubMed ID: 18395252
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1α and Interleukin-1β play a central role in the pathogenesis of fulminant hepatic failure in mice.
Sultan M; Ben-Ari Z; Masoud R; Pappo O; Harats D; Kamari Y; Safran M
PLoS One; 2017; 12(9):e0184084. PubMed ID: 28953903
[TBL] [Abstract][Full Text] [Related]
29. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts.
Labonté L; Li Y; Yang L; Gillingham A; Halpenny M; Giulivi A; Sills T; Evans K; Zanke B; Allan DS
Exp Hematol; 2009 Jun; 37(6):673-8. PubMed ID: 19463769
[TBL] [Abstract][Full Text] [Related]
30. IL-5 and eosinophilia.
Takatsu K; Nakajima H
Curr Opin Immunol; 2008 Jun; 20(3):288-94. PubMed ID: 18511250
[TBL] [Abstract][Full Text] [Related]
31. Living-related donor liver transplantation for children with fulminant hepatic failure in Israel.
Shouval DS; Mor E; Avitzur Y; Shamir R; Bar-Nathan N; Steinberg R; Schoenfeld T; Ben-Ari Z; Shapiro R
J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):451-5. PubMed ID: 19322055
[TBL] [Abstract][Full Text] [Related]
32. [Eosinophil in allergic and non-allergic inflammation].
Czarnobilska E; Obtułowicz K
Przegl Lek; 2005; 62(12):1484-7. PubMed ID: 16786779
[TBL] [Abstract][Full Text] [Related]
33. Higher serum methionine levels as a predictive factor in patients with irreversible fulminant hepatic failure.
Sato K; Fukushima D; Doi H; Satomi S
Transplant Proc; 2013 Jun; 45(5):1904-6. PubMed ID: 23769068
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
35. Pro-inflammatory interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment.
Roth GA; Faybik P; Hetz H; Hacker S; Ankersmit HJ; Bacher A; Thalhammer T; Krenn CG
Dig Liver Dis; 2009 Jun; 41(6):417-23. PubMed ID: 19019743
[TBL] [Abstract][Full Text] [Related]
36. IL-15 levels in patients with acute hepatic failure.
Yonekawa C; Nakae H; Zheng YJ; Wada H; Tanaka H; Tajimi K
Res Commun Mol Pathol Pharmacol; 2004; 115-116():5-14. PubMed ID: 17564301
[TBL] [Abstract][Full Text] [Related]
37. Course and therapy of acute liver failure.
Leifeld L; Merk P; Schmitz V; Nattermann J; Kalff JC; Hirner A; Sauerbruch T; Spengler U
Eur J Med Res; 2008 Feb; 13(2):87-91. PubMed ID: 18424368
[TBL] [Abstract][Full Text] [Related]
38. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
[TBL] [Abstract][Full Text] [Related]
39. Nimesulide associated fulminant hepatic failure.
Walker SL; Kennedy F; Niamh N; McCormick PA
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1108-12. PubMed ID: 18821716
[TBL] [Abstract][Full Text] [Related]
40. S100 beta protein: the preoperative new clinical indicator of brain damage in patients with fulminant hepatic failure.
Shiotani S; Shimada M; Soejima Y; Yoshizumi T; Uemoto S; Kiuchi T; Tanaka K; Maehara Y
Transplant Proc; 2004 Nov; 36(9):2713-6. PubMed ID: 15621131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
